India's Directorate General of Trade Remedies (DGTR) has imposed anti-dumping duties on monoisopropylamine (MIPA) imports from China, marking a significant development in the country's trade protection measures for the chemical industry.

Regulatory Action Details

The DGTR's decision to impose anti-dumping duties on Chinese MIPA imports represents a protective measure aimed at safeguarding domestic chemical manufacturers from unfair trade practices. Monoisopropylamine is an important chemical intermediate used in various industrial applications, including the production of pharmaceuticals, agrochemicals, and specialty chemicals.

Impact on Domestic Industry

This regulatory action is expected to benefit Indian chemical companies operating in the specialty chemicals segment. Alkyl Amines Chemicals and other domestic manufacturers in the amines sector may see improved market conditions as a result of these protective measures.

Market Implications

The anti-dumping duty on Chinese MIPA imports could lead to:

• Enhanced competitiveness for domestic chemical manufacturers
• Potential price stabilization in the Indian MIPA market
• Increased market share opportunities for local producers
• Strengthened position of Indian specialty chemical companies

Industry Context

The imposition of anti-dumping duties reflects the government's commitment to protecting domestic chemical manufacturers from unfair international competition. This measure aligns with India's broader strategy to strengthen its chemical manufacturing capabilities and reduce dependence on imports for critical chemical intermediates.

Alkyl Amines Chemicals has announced its Q3FY26 unaudited financial results for the quarter ended December 31, 2025. The specialty chemicals manufacturer reported a net profit of ₹42.26 crores compared to ₹43.76 crores in the corresponding quarter of the previous year, representing a decline of 3.4%. Revenue from operations also decreased to ₹354.00 crores from ₹371.20 crores in Q3FY25.

Q3FY26 Financial Performance Overview

The company's quarterly performance showed mixed results across key financial metrics. While revenue from operations declined year-on-year, the company maintained relatively stable profitability levels despite market challenges.

Nine-Month Performance Analysis

For the nine months ended December 31, 2025, the company reported revenue from operations of ₹1,148.94 crores compared to ₹1,185.77 crores in the corresponding period of the previous year. Net profit for the nine-month period stood at ₹134.64 crores versus ₹140.10 crores in the same period last year.

Earnings Per Share and Key Metrics

The company's earnings per share (basic) for Q3FY26 was ₹8.26 compared to ₹8.56 in Q3FY25. For the nine-month period, basic EPS stood at ₹26.33 versus ₹27.40 in the corresponding period of the previous year.

Board Meeting and Regulatory Compliance

The unaudited financial results were reviewed and recommended by the Audit Committee and approved by the Board of Directors at their meeting held on February 3, 2026. The Board Meeting commenced at 11:45 A.M. and concluded at 1:20 P.M. The results have been prepared in accordance with Indian Accounting Standards (Ind AS) 34 and comply with SEBI listing regulations. The statutory auditors N. M. Raiji & Co. have issued an unmodified limited review report on the quarterly and nine-month results.